DNA methylation alterations in muscle of critically ill patients

DNA methylation alterations in muscle of critically ill patients

Abstract Background Intensive care unit (ICU)‐acquired weakness can persist beyond ICU stay and has been associated with long‐term functional impairment of ICU survivors. Recently, DNA methylation alterations were found in the blood of ICU patients, partially explaining long‐term developmental impai...

Full description

Bibliographic Details
Main Authors:	Lisa Van Dyck, Fabian Güiza, Inge Derese, Lies Pauwels, Michaël P. Casaer, Greet Hermans, Pieter J. Wouters, Greet Van den Berghe, Ilse Vanhorebeek
Format:	Article
Language:	English
Published:	Wiley 2022-06-01
Series:	Journal of Cachexia, Sarcopenia and Muscle
Subjects:	Critical illness Intensive care unit‐acquired muscle weakness Muscle DNA methylation Epigenetics
Online Access:	https://doi.org/10.1002/jcsm.12970

Similar Items

Long-term impact of paediatric critical illness on the difference between epigenetic and chronological age in relation to physical growth
by: Ines Verlinden, et al.
Published: (2023-01-01)

Obesity attenuates inflammation, protein catabolism, dyslipidaemia, and muscle weakness during sepsis, independent of leptin
by: Wouter Vankrunkelsven, et al.
Published: (2022-02-01)

Development of muscle weakness in a mouse model of critical illness: does fibroblast growth factor 21 play a role?
by: Wouter Vankrunkelsven, et al.
Published: (2023-08-01)

Assessment of aberrant DNA methylation two years after paediatric critical illness: a pre-planned secondary analysis of the international PEPaNIC trial
by: Grégoire Coppens, et al.
Published: (2023-12-01)

Altered cholesterol homeostasis in critical illness-induced muscle weakness: effect of exogenous 3-hydroxybutyrate
by: Chloë Goossens, et al.
Published: (2021-07-01)

Abnormal DNA methylation within HPA-axis genes years after paediatric critical illness
by: Grégoire Coppens, et al.
Published: (2024-02-01)

The clinical potential of GDF15 as a “ready-to-feed indicator” for critically ill adults
by: Lisa Van Dyck, et al.
Published: (2020-09-01)

Towards a fasting-mimicking diet for critically ill patients: the pilot randomized crossover ICU-FM-1 study
by: Lisa Van Dyck, et al.
Published: (2020-05-01)

Abnormal DNA methylation within genes of the steroidogenesis pathway two years after paediatric critical illness and association with stunted growth in height further in time
by: Ilse Vanhorebeek, et al.
Published: (2023-07-01)

Impact of duration of critical illness and level of systemic glucocorticoid availability on tissue-specific glucocorticoid receptor expression and actions: A prospective, observational, cross-sectional human and two translational mouse studies
by: Arno Téblick, et al.
Published: (2022-06-01)

Adipose tissue protects against sepsis-induced muscle weakness in mice: from lipolysis to ketones
by: Chloë Goossens, et al.
Published: (2019-07-01)

The use of muscle ultrasound to detect critical illness myopathy in patients with sepsis: an observational cohort study
by: Mostafa M. Elkholy, et al.
Published: (2024-02-01)

Identification of the toxic threshold of 3-hydroxybutyrate-sodium supplementation in septic mice
by: Ruben Weckx, et al.
Published: (2021-09-01)

Phasing out DEHP from plastic indwelling medical devices used for intensive care: Does it reduce the long-term attention deficit of critically ill children?
by: Ilse Vanhorebeek, et al.
Published: (2022-01-01)

Impact of prolonged sepsis on neural and muscular components of muscle contractions in a mouse model
by: Chloë Goossens, et al.
Published: (2021-04-01)

The rate and assessment of muscle wasting during critical illness: a systematic review and meta-analysis
by: Brigitta Fazzini, et al.
Published: (2023-01-01)

The soluble mannose receptor (sMR/sCD206) in critically ill patients with invasive fungal infections, bacterial infections or non-infectious inflammation: a secondary analysis of the EPaNIC RCT
by: Greet De Vlieger, et al.
Published: (2019-08-01)

Prolonged glucocorticoid treatment in ARDS: impact on intensive care unit acquired weakness.
by: Gianfranco Umberto Meduri, et al.
Published: (2016-08-01)

Editorial: Muscle dysfunction of critical illness
by: Dmitry Rozenberg, et al.
Published: (2023-11-01)

Anterior pituitary function in critical illness
by: Arno Téblick, et al.
Published: (2019-08-01)

Leukocyte telomere length in paediatric critical illness: effect of early parenteral nutrition
by: Sören Verstraete, et al.
Published: (2018-02-01)

Novel High-Quality Sonographic Methods to Diagnose Muscle Wasting in Long-Stay Critically Ill Patients: Shear Wave Elastography, Superb Microvascular Imaging and Contrast-Enhanced Ultrasound
by: Carmen Rosa Hernández-Socorro, et al.
Published: (2021-06-01)

Ultrasonographic Features of Muscular Weakness and Muscle Wasting in Critically Ill Patients
by: Michele Umbrello, et al.
Published: (2023-12-01)

Impact of tight glucose control on circulating 3-hydroxybutyrate in critically ill patients
by: Jan Gunst, et al.
Published: (2021-10-01)

The association of hypoglycemia with outcome of critically ill children in relation to nutritional and blood glucose control strategies
by: Jan Gunst, et al.
Published: (2023-06-01)

The hypothalamus-pituitary-adrenal axis in sepsis- and hyperinflammation-induced critical illness: Gaps in current knowledge and future translational research directions
by: Greet Van den Berghe, et al.
Published: (2022-10-01)

Intensive care unit-acquired weakness: Recent insights
by: Juan Chen, et al.
Published: (2024-01-01)

Bioimpedance-assessed muscle wasting and its relation to nutritional intake during the first week of ICU: a pre-planned secondary analysis of Nutriti Study
by: Cristian Deana, et al.
Published: (2024-02-01)

Impact of critical illness and withholding of early parenteral nutrition in the pediatric intensive care unit on long-term physical performance of children: a 4-year follow-up of the PEPaNIC randomized controlled trial
by: Ilse Vanhorebeek, et al.
Published: (2022-05-01)

Impact of tight blood glucose control within normal fasting ranges with insulin titration prescribed by the Leuven algorithm in adult critically ill patients: the TGC-fast randomized controlled trial
by: Jan Gunst, et al.
Published: (2022-09-01)

Safety and Feasibility Assessment of Repetitive Vascular Occlusion Stimulus (RVOS) Application to Multi-Organ Failure Critically Ill Patients: A Pilot Randomised Controlled Trial
by: Ismita Chhetri, et al.
Published: (2022-07-01)

Exercise overcomes muscle weakness following on trauma and critical illness
by: H. Van Aswegen, et al.
Published: (2008-02-01)

Disintegration of the NuRD Complex in Primary Human Muscle Stem Cells in Critical Illness Myopathy
by: Joanna Schneider, et al.
Published: (2023-02-01)

Repetitive vascular occlusion stimulus (RVOS) versus standard care to prevent muscle wasting in critically ill patients (ROSProx):a study protocol for a pilot randomised controlled trial
by: Ismita Chhetri, et al.
Published: (2019-07-01)

Intensive Care Unit-Acquired Weakness: Not Just Another Muscle Atrophying Condition
by: Heta Lad, et al.
Published: (2020-10-01)

Toward nutrition improving outcome of critically ill patients: How to interpret recent feeding RCTs?
by: Jan Gunst, et al.
Published: (2023-01-01)

Intensive care unit-acquired weakness: From molecular mechanisms to its impact in COVID-2019
by: Andrea Gonzalez, et al.
Published: (2022-08-01)

Programmed myofibre necrosis in critical illness acquired muscle wasting
by: Sunil Patel, et al.
Published: (2023-07-01)

Critical illness myopathy after COVID-19
by: Sergio Bagnato, et al.
Published: (2020-10-01)

Development and validation of the creatinine clearance predictor machine learning models in critically ill adults
by: Chao-Yuan Huang, et al.
Published: (2023-07-01)